All
Phase 2 Trial of ADX-629 Underway for Treatment of AD
ADX‑629 also is being evaluated in Phase 2 clinical trials for the treatment of chronic cough, idiopathic nephrotic syndrome, and Sjögren-Larsson Syndrome.
Millennials, Gen Xers Increase Risk of Nonmelanoma Skin Cancer
A new survey found that the demographics are not following safe sun habits and have low skin cancer awareness.
Asthma, Eczema Associated With Higher Risk for Osteoarthritis
The study suggests that treatments for allergic reactions could help decrease the risk of having joint problems.
Spring into Rejuvenated Goals in Your Practice
Preventing Laser, Light Therapy-Induced Lesions in Vitiligo
Researchers said laser and intense pulse light-induced vitiligo lacks consensus in prevention and safety measures.
The Mainstream Patient: April 10
This week's edition of the Mainstream Patient features stories about filler fatigue in 2023, the difference between RF microneedling and traditional microneedling, IPL hair removal devices, and more.
POLL: What Disease is Associated with Dermatitis Herpetiformis?
Click here to answer this week's poll.
Cancer Treatment's Checkpoint Inhibitors Are Causing Skin-Related Adverse Events
Checkpoint inhibitors such as pembrolizumab nivolumab are playing a major role in cancer treatment, but they can also produce adverse events that affect the skin.
The Weekly Roundup: April 3-7
ICYMI, this week we had stories about the role of dermatology advanced practice providers in a clinic, denovoSkin for severe burns, spesolimab receiving a permanent J-code, and more.
Trial of Lead Atopic Dermatitis Drug Reports Unsatisfactory Results
Researchers say itch and inflammation markers were not met, and trial results are not conclusive.
Fatty Liver More Frequent in Alopecia Universalis and Patchy Alopecia Areata
Investigators examined the association between fatty liver and AA subtypes.
Acne, Skin Appearance Improved With Salicylic and Lipohydroxy Acids
Researchers said a facial serum and mask containing both acids resulted in statistically significant improvements to the skin.
Spesolimab-sbzo Receives a New, Permanent J-code
Mark Lebwohl, MD said it is a step forward for patients diagnosed with generalized pustular psoriasis.
New Positive Phase 1 & 2 Results of DenovoSkin for Burns
Cutiss AG hopes to provide a safe and effective skin substitute for patients needing a skin graft after a severe burn.
Interventions in Minimal Residual Disease Lead to Long-Term Melanoma Control
In a recent review, authors explored the effects of targeted therapies and immune checkpoint inhibitors on melanoma, particularly in minimal residual disease.
Matrikyne Peptides Safe and Effective in Improving Skin Appearance
Following a clinical trial, Xylyx Bio’s Matrikyne ingredient was deemed efficacious in combatting anti-aging effects and improving skin appearance.
Pointers With Portela: How to Combat Wrinkles
In this week’s Pointers with Portela, the 208SkinDoc goes to Ulta Beauty to find the best skin care products for treating wrinkles.
Tranexamic Acid Minimizes Volume, Area of Wrinkles
Researchers say the treatment, which is known to treat pigmented disorders, is also effective in treating periorbital wrinkling.
Zoe Draelos, MD, Gives Pearls on Treating Rosacea
April has been designated Rosacea Awareness Month by The National Rosacea Society (NRS) in an effort to educate the public on the impact of this chronic and widespread facial disorder.
The Future of Immunotherapy Targets
With the advent of immunotherapy, the 1-year survival rate for patients with metastatic melanoma has increased from 25% to 50%.
The Role of Dermatology Advanced Practice Providers With Shanna Miranti, PA-C
Dermatology advanced practice providers work alongside physicians to improve patient care and access.
Phase 2 KEYNOTE-695 Trial for Melanoma Treatment Did Not Reach Primary Endpoint
Patients in the clinical trial had confirmed disease progression after 12 weeks.
National Rosacea Awareness Month: Pearls and Best Practices
The Dermatology Times® team is spotlighting rosacea treatments during this Rosacea Awareness Month.
Use of Carboxytherapy in Dermatologic, Cosmetic Concerns
Carboxytherapy has been successful in treating several indications, such as cellulite, hyperpigmentation, scarring, and more.
Laser Therapy Trials Lack Skin of Color Representation
Researchers say skin phototypes 5 and 6 lack representation in laser and light therapy trials.
Cynthia Elliott, MD, Discusses Correlation Between Cosmetic Procedures and the COVID-19 Pandemic
Physicians across the US saw an uptick in cosmetic procedures after workers returned to offices.
Expert Treatment Tips You Don’t Want to Miss
From acne and psoriasis to skin cancer and hair loss, leaders in the industry share their quick tips that help save time.
IDP-126 Gel Demonstrates Superior Efficacy in Moderate-to-Severe Acne
Researchers said the treatment is both efficacious and safe in patients ages 9 and older.
COVID-19's Impact on Treating Elderly Patients With Skin Cancer
Researchers said the pandemic played a role in healthcare providers’ ability to safely and promptly treat various skin cancers.
The Mainstream Patient: April 3
This week's edition of the Mainstream Patient features stories about inclusivity in plastic surgery, the powerful benefits of glycerin, the best mineral sunscreens according to dermatologists, and more.
